The University of Edinburgh
Molecular drivers of CNS disease in a murine model of infant leukaemia
Abstract
dc:description.abstractInfant leukaemia is a rare, aggressive entity with poor outcomes. Infant leukaemia is defined by the age of the patient, less than one year, and is commonly associated with rearrangements of the MLL gene. There are many unique features that distinguish MLL rearranged infant leukaemia from other paediatric leukaemias, including a high rate of central nervous system (CNS) involvement. CNS involvement is typically a leukaemic infiltrate of the meninges, a niche that is very different from the primary site of disease, the bone marrow (BM), in terms of nutrient abundance and cellular composition. While our understanding of how leukaemia cells survive and propagate in the CNS has progressed, there are many unanswered questions about infant leukaemia-specific features and the contribution of the niche. This thesis explores the cellular dynamics of leukaemia in the CNS niche, the differential regulation of immune cell interactions and growth factor pathways through transplantation assays, bulk RNA sequencing and functional experiments. In previous studies, two microRNAs (miR-128a and miR-130b) were identified as being upregulated in MLL-AF4+ infant patient samples. Overexpression of these microRNAs individually in mouse fetal liver haematopoietic stem and progenitor cells resulted in microRNA-dependent lineage-specific acute leukaemias in the context of Mll- AF4. Terminal leukaemia development in these immunocompetent models of infant leukaemia was associated with CNS involvement in a leptomeningeal distribution representative of human disease. These mouse models form the foundation of the investigation of CNS niche-specific features in infant leukaemia in this thesis. The functional properties of leukaemia propagating cells (LPC) in both niches, in either model, were explored. Data are presented that show different LPCs are very similar, are able to give rise to one another and are all represented in the CNS niche. Further transplantation assays show a lasting functional impact on LPCs and their ability to repopulate leukaemia following exposure to the CNS niche in both model systems. The thesis goes on to strengthen these findings by describing the transcriptomic differiv ences between these LPCs. The RNA sequencing data generated are also used to validate the miR-128a overexpression Mll-AF4, or pro-B infant acute lymphoblastic leukaemia, model. The next section of the thesis outlines transcriptomic differences between LPCs from the CNS and BM niches in both models. The discussion focuses on comparisons to existing datasets and on two novel differentially regulated processes; interaction with immune cells and growth factor signalling. Subsequent sections present functional followup experiments exploring these two novel themes. The data shown describe nichespecific differences in macrophage, T cell and NK cell dynamics and, of particular interest, imply suppression of anti-leukaemia macrophage and T cell responses in the CNS niche. In the final section, increased activation of the PI3K pathway in CNS-derived compared with BM-derived leukaemia cells is explored through downregulation of the inhibitory regulator PTEN.MiR-93, which targets PTENand CDKN1A, a downstream target of the PI3K pathway, is proposed as a global regulator of this cell-intrinsic niche-specific pathway activation. miR-93 is shown to be upregulated in CNS-derived leukaemia cells in the miR-128a overexpressionMll-AF4 model and three independent infant leukaemia patient-derived xenograft models. To conclude this section, suppression of miR-93 activity is shown to impair leukaemia cell engraftment to the CNS niche. Overall, this thesis will put forward new insights into cell-intrinsic and cell-extrinsic mechanisms of leukaemia cell survival and propagation within the CNS niche in infant leukaemia murine models.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Duguid, Alasdair John
- Advisors dc:contributor.advisor
-
- Ottersbach, Katrin
- Halsey, Christina
Subjects
dc:subject × 16- CNS disease
- molecular drivers of CNS disease
- infant leukaemia
- murine model of infant leukaemia
- distinguishMLLrearranged infant leukaemia
- paediatric leukaemia
- central nervous system (CNS)
- bone marrow (BM)
- miR-128a
- miR-130b
- MLL-AF4+
- leukaemia propagating cells (LPC)
- Mll-AF4
- pro-B infant acute lymphoblastic leukaemia
- inhibitory regulator PTEN
- leukaemia cell survival
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/4089